Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R2R01 plus Terlipressin in HRS-AKI
NCT05875948Phase 2Unknown
- Sponsor
- River 2 Renal Corp
- Start
- Jun 2023
- Primary completion
- Dec 2024
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of R2R01 in hepatorenal syndrome (HRS), sponsored by River 2 Renal Corp. Status: unknown.
02
Drugs
R2R01
03
Conditions
hepatorenal syndrome (HRS)
Beyond the preview
Go deeper on NCT05875948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05875948.